 Adam Terella
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Facial Neoplasms | 2 | 2019 | 19 | 1.230 |
Why?
| | Skin Neoplasms | 5 | 2021 | 855 | 1.220 |
Why?
| | Mohs Surgery | 4 | 2021 | 27 | 1.100 |
Why?
| | Forehead | 3 | 2019 | 6 | 0.960 |
Why?
| | Tissue Expansion | 2 | 2021 | 10 | 0.820 |
Why?
| | Dermatofibrosarcoma | 2 | 2019 | 9 | 0.770 |
Why?
| | Skull Base Neoplasms | 1 | 2022 | 30 | 0.750 |
Why?
| | Surgical Flaps | 3 | 2021 | 130 | 0.620 |
Why?
| | Cheek | 1 | 2019 | 17 | 0.620 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 20 | 0.600 |
Why?
| | Postoperative Complications | 5 | 2022 | 2654 | 0.600 |
Why?
| | Endoscopy | 3 | 2022 | 318 | 0.580 |
Why?
| | Skin | 1 | 2021 | 752 | 0.520 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 1079 | 0.420 |
Why?
| | Blepharoplasty | 1 | 2013 | 10 | 0.410 |
Why?
| | Eyebrows | 1 | 2012 | 3 | 0.400 |
Why?
| | Eyelids | 1 | 2013 | 37 | 0.400 |
Why?
| | Rhytidoplasty | 1 | 2012 | 4 | 0.390 |
Why?
| | Orbit | 1 | 2013 | 70 | 0.380 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2010 | 66 | 0.330 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 95 | 0.310 |
Why?
| | Skull | 1 | 2010 | 139 | 0.310 |
Why?
| | Osteogenesis | 1 | 2010 | 188 | 0.290 |
Why?
| | Polyethylene Glycols | 2 | 2010 | 641 | 0.280 |
Why?
| | Biopolymers | 1 | 2022 | 31 | 0.190 |
Why?
| | Chinchilla | 1 | 2022 | 34 | 0.190 |
Why?
| | Skull Base | 1 | 2022 | 53 | 0.190 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2022 | 62 | 0.180 |
Why?
| | Surgical Wound | 1 | 2021 | 23 | 0.180 |
Why?
| | Scalp | 1 | 2021 | 35 | 0.180 |
Why?
| | Perfusion | 1 | 2021 | 213 | 0.170 |
Why?
| | Carcinoma, Basal Cell | 1 | 2021 | 75 | 0.170 |
Why?
| | Sulfhydryl Compounds | 1 | 2022 | 189 | 0.160 |
Why?
| | Accessory Nerve Injuries | 1 | 2017 | 2 | 0.140 |
Why?
| | Wound Healing | 1 | 2020 | 331 | 0.140 |
Why?
| | Cranial Fossa, Anterior | 1 | 2017 | 2 | 0.130 |
Why?
| | Arm | 1 | 2017 | 104 | 0.130 |
Why?
| | Interferon-alpha | 3 | 2009 | 198 | 0.130 |
Why?
| | Humans | 17 | 2022 | 137585 | 0.130 |
Why?
| | Bone Transplantation | 1 | 2017 | 90 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 606 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2017 | 179 | 0.120 |
Why?
| | Antiviral Agents | 3 | 2009 | 744 | 0.120 |
Why?
| | Hepatitis C | 2 | 2009 | 271 | 0.100 |
Why?
| | Hematoma | 1 | 2013 | 53 | 0.100 |
Why?
| | Skin Aging | 1 | 2012 | 20 | 0.100 |
Why?
| | Rejuvenation | 1 | 2012 | 19 | 0.100 |
Why?
| | Corneal Injuries | 1 | 2013 | 44 | 0.100 |
Why?
| | Ribavirin | 2 | 2003 | 91 | 0.090 |
Why?
| | Postoperative Hemorrhage | 1 | 2013 | 86 | 0.090 |
Why?
| | Dry Eye Syndromes | 1 | 2013 | 54 | 0.090 |
Why?
| | Liver Transplantation | 3 | 2004 | 871 | 0.090 |
Why?
| | Vision Disorders | 1 | 2013 | 142 | 0.090 |
Why?
| | Hepatitis C, Chronic | 2 | 2004 | 164 | 0.090 |
Why?
| | Anhydrides | 1 | 2010 | 18 | 0.080 |
Why?
| | Norbornanes | 1 | 2010 | 15 | 0.080 |
Why?
| | Histiocytoma | 1 | 2009 | 2 | 0.080 |
Why?
| | Neurothekeoma | 1 | 2009 | 4 | 0.080 |
Why?
| | X-Ray Microtomography | 1 | 2010 | 94 | 0.080 |
Why?
| | Post-Exposure Prophylaxis | 1 | 2009 | 9 | 0.080 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 21 | 0.080 |
Why?
| | Photochemistry | 1 | 2010 | 134 | 0.080 |
Why?
| | Soft Tissue Neoplasms | 1 | 2009 | 115 | 0.070 |
Why?
| | Hepacivirus | 3 | 2009 | 261 | 0.070 |
Why?
| | Tissue Scaffolds | 1 | 2010 | 211 | 0.070 |
Why?
| | Retrospective Studies | 3 | 2022 | 15657 | 0.070 |
Why?
| | RNA, Viral | 3 | 2009 | 656 | 0.060 |
Why?
| | Middle Aged | 6 | 2021 | 33479 | 0.060 |
Why?
| | Animals | 3 | 2022 | 36940 | 0.060 |
Why?
| | Male | 8 | 2021 | 67762 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2486 | 0.060 |
Why?
| | Rats | 2 | 2010 | 5647 | 0.050 |
Why?
| | Health Personnel | 1 | 2009 | 710 | 0.050 |
Why?
| | Spatial Behavior | 1 | 2002 | 26 | 0.050 |
Why?
| | Retreatment | 1 | 2021 | 72 | 0.050 |
Why?
| | Multiple Trauma | 1 | 2002 | 100 | 0.040 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2004 | 362 | 0.040 |
Why?
| | Preoperative Period | 1 | 2021 | 129 | 0.040 |
Why?
| | Virus Replication | 1 | 2002 | 483 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 624 | 0.040 |
Why?
| | Liver Neoplasms | 1 | 2004 | 786 | 0.040 |
Why?
| | Motor Activity | 1 | 2002 | 718 | 0.030 |
Why?
| | Bone Regeneration | 1 | 2017 | 26 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 708 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2004 | 1208 | 0.030 |
Why?
| | Electromyography | 1 | 2017 | 400 | 0.030 |
Why?
| | Brain Concussion | 1 | 2002 | 574 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2009 | 1353 | 0.030 |
Why?
| | Viral Load | 2 | 2004 | 466 | 0.020 |
Why?
| | Cohort Studies | 2 | 2017 | 5742 | 0.020 |
Why?
| | Mutation | 1 | 2002 | 3958 | 0.020 |
Why?
| | Needlestick Injuries | 1 | 2009 | 4 | 0.020 |
Why?
| | Female | 7 | 2017 | 73304 | 0.020 |
Why?
| | Blood-Borne Pathogens | 1 | 2009 | 7 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2009 | 10811 | 0.020 |
Why?
| | Adult | 5 | 2017 | 37929 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5131 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2691 | 0.020 |
Why?
| | Occupational Exposure | 1 | 2009 | 341 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2009 | 1483 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1710 | 0.010 |
Why?
| | Prednisolone | 1 | 2003 | 83 | 0.010 |
Why?
| | Aspartate Aminotransferases | 1 | 2003 | 90 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2002 | 95 | 0.010 |
Why?
| | Swimming | 1 | 2002 | 51 | 0.010 |
Why?
| | HIV | 1 | 2003 | 234 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 2002 | 125 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1325 | 0.010 |
Why?
| | Random Allocation | 1 | 2002 | 353 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 696 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2004 | 1389 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 384 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2004 | 1509 | 0.010 |
Why?
| | Acute Disease | 1 | 2003 | 1007 | 0.010 |
Why?
| | Aged | 3 | 2004 | 23961 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1060 | 0.010 |
Why?
| | Base Sequence | 1 | 2002 | 2181 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2003 | 594 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 2139 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2003 | 890 | 0.010 |
Why?
| | Islets of Langerhans | 1 | 2004 | 803 | 0.010 |
Why?
| | Genetic Variation | 1 | 2002 | 991 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 5778 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 2847 | 0.010 |
Why?
| | Infant | 1 | 2009 | 9465 | 0.010 |
Why?
| | Child, Preschool | 1 | 2009 | 11074 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2004 | 5472 | 0.010 |
Why?
| | Child | 1 | 2009 | 21935 | 0.000 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2004 | 2531 | 0.000 |
Why?
| | Adolescent | 1 | 2004 | 21513 | 0.000 |
Why?
|
|
Terella's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|